𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New drug strategies in the treatment of senile dementia of different origin

✍ Scribed by Kevin L. Keim; Béla Kiss

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
53 KB
Volume
14
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials with the cholinergic dru
Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)
✍ Albert Wettstein; René Spiegel 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 216 KB

The muscarinic agonist RS 86 was administered to patients with Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT) in a series of controlled clinical trials. Daily doses were up to 3.0 mg orally for a maximum duration of 18 weeks. RS 86 produced typical peripheral cholinergic e

New drugs in the treatment of colorectal
New drugs in the treatment of colorectal carcinoma
✍ Cornelis J. A. Punt 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 3 views

## BACKGROUND. Treatment with 5-fluorouracil (5-FU) plus leucovorin has been the unofficial standard therapy for patients with colorectal carcinoma (CRC) for more than a decade; however, the optimal dose and schedule remain a matter of debate. Recently several new drugs have shown activity in thi

New delivery techniques in the drug trea
New delivery techniques in the drug treatment of Parkinson's disease
✍ W. Poewe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

A marked response to oral dopaminergic substitution is one of the diagnostic criteria for idiopathic Parkinson's disease. Oral L-Dopa treatment remains to be the most efficacious and best tolerated way of parkinsonian drug therapy. A majority of patients, however, will develop late complications inc